Search

Vaijinath S Kamanna

from Irvine, CA
Age ~68

Vaijinath Kamanna Phones & Addresses

  • 135 Yellow Pne, Irvine, CA 92618 (714) 675-0561
  • 29 Twiggs, Irvine, CA 92620 (949) 387-0326
  • 59 Arborwood, Irvine, CA 92620 (714) 389-6610 (949) 389-6610
  • 3609 2Nd St, Long Beach, CA 90803 (714) 621-1990 (562) 621-1990
  • 3700 Plaza Dr, Santa Ana, CA 92704
  • Orange, CA
  • 59 Arborwood, Irvine, CA 92620 (949) 677-0936

Work

Company: Department of veterans affairs Apr 2009 to May 2013 Position: Coordinating director

Education

Degree: Doctorates, Doctor of Philosophy School / High School: Central Food Technological Research Institute, Mysore, India Specialities: Biochemistry, Biology, Philosophy

Skills

Medical Research • Clinical Trials • Medical Affairs • Cardiovascular Disease • Atherosclerosis • Management • Lipoproteins • Project Management • Irb Document Preparation • Clinical Trial Budgeting • Clinical Trial Protocol Preparation • Medical Writing • Scientific Writing • Drug Discovery • Expert Reviewer For Scientific and Medic... • Fatty Liver Disease • Renal Disease • Diabetes

Interests

Clinical Trials • Management • Health Care

Industries

Research

Resumes

Resumes

Vaijinath Kamanna Photo 1

Associate Director

View page
Location:
Irvine, CA
Industry:
Research
Work:
Department of Veterans Affairs Apr 2009 - May 2013
Coordinating Director

Apr 2009 - May 2013
Associate Director
Education:
Central Food Technological Research Institute, Mysore, India
Doctorates, Doctor of Philosophy, Biochemistry, Biology, Philosophy
The Ohio State University
Skills:
Medical Research
Clinical Trials
Medical Affairs
Cardiovascular Disease
Atherosclerosis
Management
Lipoproteins
Project Management
Irb Document Preparation
Clinical Trial Budgeting
Clinical Trial Protocol Preparation
Medical Writing
Scientific Writing
Drug Discovery
Expert Reviewer For Scientific and Medical Journals
Fatty Liver Disease
Renal Disease
Diabetes
Interests:
Clinical Trials
Management
Health Care

Publications

Us Patents

Indication For Use Of Niacin (Nicotinic Acid) For Treatment, Prevention And Reversal Of Fatty Liver Disease

View page
US Patent:
20130303548, Nov 14, 2013
Filed:
Nov 22, 2011
Appl. No.:
13/988972
Inventors:
Moti L. Kashyap - Rancho Palos Verdes CA, US
Shobha V. Kamanna - Irvine CA, US
Vaijinath S. Kamanna - Irvine CA, US
Assignee:
The Regents of the University of California - Oakland CA
International Classification:
A61K 31/455
A61K 45/06
C07D 213/80
US Classification:
51425506, 514356, 514355, 514350, 514473, 514332, 514277, 514247, 546318
Abstract:
Niacin prevents and/or reverses the development of experimental hepatic steatosis, deposition of triglycerides in liver and serum of individuals, deposition of total cholesterol in liver and serum in individuals, and inhibit liver lipid peroxidation and oxidative stress in individuals at risk of developing fatty liver disease or NAFLD. In cultured human hepatocytes, niacin inhibits alcohol-induced fat accumulation.
Vaijinath S Kamanna from Irvine, CA, age ~68 Get Report